In a murine model of chronic myeloid leukemia, we previously determined that inhibition of Fap1 decreased persistence of leukemia stem cells during tyrosine kinase inhibitor treatment. The gene discussed is PTPN13; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.